valuation workbook
TRANSCRIPT
-
8/10/2019 Valuation Workbook
1/48
Key: Input DataValuation Calculations
2004 2005 2006 2007 2008Book Value per Share (BV) 1.36 1.41 1.48 1.59 1.72Earnings per Share (EPS) 0.11 0.07 0.12 0.17 0.20Dividends per Share 0.05 0.02 0.05 0.05 0.05Shares Out (Millions) 2600.5 2600.5 2600.5 2600.5 2600.5Price-Earnings Ratio (P/E) - high 61.4 19.8 29.6 33.4Price-Earnings Ratio (P/E) - low 26.0 10.0 8.2 5.5Revenue 141 138 165 180 176Net Income 3 2 3 4 5Shareholder Equity 26 26 26 26 26
2004 2005 2006 2007 2008Book Yield (per Share) 8.1% 5.0% 8.1% 10.7% 11.6%Book Yield (Return On Equity-ROE) 10.6% 7.2% 11.8% 16.8% 19.7%Payout Ratio 45.5% 28.6% 41.7% 29.4% 25.0%Retention Ratio 54.5% 71.4% 58.3% 70.6% 75.0%
Growth in Book Value (BV) 23.59%Return On Equity (ROE) 26.21%
Percent Earnings Return 90.02%Payout Ratio 9.98%
Estimated Estimated Estimated Estimated
2015 2016 2017 2018Book Value per Share (BV) 47.25 58.40 72.18 89.21Earnings per Share (EPS) 12.38 15.31 18.92 23.38
Low Avg. Median HighP/E P/E P/E P/E
Future P/E 3.0 18.1 7.7 100.1Future Price per Share 245.96 1504.27 639.84 8344.21
Estimated Estimated Estimated Estimated
2015 2016 2017 2018Common Dividends 1.24 1.53 1.89 2.33
Current Price per Share 41.00
Today's Estimated Estimated Estimated Estimated
Cash Flows Price 2015 2016 2017 2018
The Buffet Approa
STEP 1:
ST
STEPS 3
STEP 5: Esti
STEP 6: Calc
-
8/10/2019 Valuation Workbook
2/48
Low P/E Assumption Return -41.00 1.24 1.53 1.89 2.33Average P/E Assumption Return -41.00 1.24 1.53 1.89 2.33Median P/E Assumption Return -41.00 1.24 1.53 1.89 2.33High P/E Assumption Return -41.00 1.24 1.53 1.89 2.33
30.7% 4 6 87% 6.4% 10.0% 12.7%8% 7.3% 11.0% 13.6%9% 8.3% 11.9% 14.6%
10% 9.2% 12.8% 15.6%11% 10.1% 13.8% 16.5%12% 11.0% 14.7% 17.5%13% 11.9% 15.7% 18.5%14% 12.8% 16.6% 19.4%15% 13.7% 17.5% 20.4%
0.00016148 0.033954272 0.059131952GrowthinBookValue
-
8/10/2019 Valuation Workbook
3/48
10-YearAverage2009 2010 2011 2012 2013 2014 Growth
1.85 2.20 2.52 2.97 36.93 38.23 39.60%0.19 0.41 0.35 0.40 8.42 10.02 57.02%0.05 0.05 0.05 0.07 1.00 1.00 82.06%
2600.5 2600.5 4823 4823 4823 6813 10.11%13.9 6.3 8.6 100.1 7.1 5.575.4 4.0 5.1 4.9 3.0 3.0
229 309 377 456 664 910 20.49%5 11 17 19 41 59 35.86%26 26 48 48 48 68 10.11%
2009 2010 2011 2012 2013 2014 Median10.3% 18.6% 13.9% 13.5% 22.8% 26.2% 11.6%18.5% 40.9% 35.0% 40.2% 84.2% 86.5% 19.7%26.3% 12.2% 14.3% 17.5% 11.9% 10.0% 25.0%73.7% 87.8% 85.7% 82.5% 88.1% 90.0% 75.0%
Estimated Estimated Estimated Estimated Estimated Estimated
2019 2020 2021 2022 2023 2024110.25 136.27 168.42 208.15 257.27 317.9728.90 35.72 44.14 54.56 67.43 83.34
Estimated Estimated Estimated Estimated Estimated Estimated
2019 2020 2021 2022 2023 20242.88 3.56 4.41 5.44 6.73 8.32
Estimated Estimated Estimated Estimated Estimated Estimated Expected
2019 2020 2021 2022 2023 2024 Price
h to Valuing Stocks: Arvind Remedies
et up spreadsheet with raw data
EP 2: Calculate book yield
& 4: Estimate future BV and EPS
ate future P/E ratio and stock price
ulate expected return on investment
-
8/10/2019 Valuation Workbook
4/48
2.88 3.56 4.41 5.44 6.73 8.32 245.962.88 3.56 4.41 5.44 6.73 8.32 1504.272.88 3.56 4.41 5.44 6.73 8.32 639.842.88 3.56 4.41 5.44 6.73 8.32 8344.21
10 12 14 16 18 2014.8% 16.6% 18.2% 19.5% 20.8% 21.9%15.8% 17.6% 19.2% 20.6% 21.8% 22.9%16.8% 18.6% 20.2% 21.6% 22.8% 23.9%17.8% 19.6% 21.2% 22.6% 23.9% 25.0%18.7% 20.6% 22.2% 23.6% 24.9% 26.0%19.7% 21.6% 23.2% 24.6% 25.9% 27.1%20.7% 22.6% 24.2% 25.6% 26.9% 28.1%21.7% 23.6% 25.2% 26.7% 28.0% 29.1%22.7% 24.6% 26.2% 27.7% 29.0% 30.2%
0.079327501 0.096252975 0.110857814 0.123725675 0.13524201 0.145675205
TEP 7: Interpret results
P/E Ratio 10 Years from Today
-
8/10/2019 Valuation Workbook
5/48
10-YearCumulativeGrowth Median2711.03%9009.09%1900.00%
161.99%16.9
5.3545.14%
2041.82%161.99%
AnnualExpected
Rate of
Return
-
8/10/2019 Valuation Workbook
6/48
21.1%40.5%30.7%63.2%
-
8/10/2019 Valuation Workbook
7/48
Name Arvind Remedies
Industry Pharmaceuticals
Market Cap (Cr) 318.15Exchange BSE
Sr. No. Competitor Price EPS PE ratio1 100 10 1023456789
101112
1314151617181920
Average 10
100
96100Result Reasonable
CurrentCurrent
Price Based on PE ratio
Price Based on PS ratioPrice Based on PBV ratio
CurrentCurr
-
8/10/2019 Valuation Workbook
8/48
20010 208 25
10 20
Sales, Cr. Shares, Cr Sales / Share PS ratio BV / share PBV Ratio100 12 8.3 12 10 10
12 10
Current PE ratio ales/share Current PS ratio
BV/share Current PBV ratio
arket Pricent EPS
-
8/10/2019 Valuation Workbook
9/48
Ticker AAPL
Company infoNameIndustry
Market Cap (Cr)Exchange
Score
75 out of 100 $272P/E Valuation
Fundamentals Judgement Points WeightReturn on Equity Good 9.09 5 Average estimateDebt/Equity Good 9.09 5 The estimate is
Conservative PEG ratio Good 1.82 1 Current share priceP/E ratio Good 3.64 2 UndervaluedNet margin Good 5.45 3 Max purchase priceBookvalue per share Good 9.09 5Growth rate next 5yr Relatively low 0.00 1FCF yield Low 0.00 1Asset turnover change Good 7.27 4Current ratio Bad 0.00 5Altman Z Score Bad 0.00 3Accrual profit Reasonable 5.45 3Defensive profit Positive & increasing 5.45 3Enterprising profit Bad 0.00 4
Debt Repayment Period Good 18.18 10 Tutorials:55 Support:
Creation date:
Pharmaceuticals
1. Click File > Make a copy.. to get your own version of this spreadsheet
Arvind Remedies
8/31/2014 10:33:00
$318BSE
Intrinsic value estimates
Price info
-
8/10/2019 Valuation Workbook
10/48
-
8/10/2019 Valuation Workbook
11/48
-
8/10/2019 Valuation Workbook
12/48
-
8/10/2019 Valuation Workbook
13/48
-
8/10/2019 Valuation Workbook
14/48
-
8/10/2019 Valuation Workbook
15/48
In Millions of USD (except for per share items)
52 weeks ending
2013-09-28
52 weeks ending
2012-09-29
Revenue 911.11 664.26Other Revenue, Total 0.47 0.59Total Revenue 911.57 664.85Cost of Revenue, Total 702.51 509.38Gross Profit 209.06 155.47Selling/General/Admin. Expenses, Total 0 0Research & Development 0 0Depreciation/Amortization 13.9 12.59Interest Expense(Income) - Net Operating 0 0Unusual Expense (Income) - -Other Operating Expenses, Total 31.66 21.15Total Operating Expense 45.56 33.74Operating Income 163.5 121.73
Interest Income(Expense), Net Non-Operating 77.1 59.19Gain (Loss) on Sale of Assets - -Other, Net - -Income Before Tax 86.4 62.54Income After Tax 58.84 40.62Minority Interest - -Equity In Affiliates - -Net Income Before Extra. Items 58.84 40.62Accounting Change 0.06 0Discontinued Operations - -Extraordinary Item - -Net Income 58.9 40.62
Preferred Dividends - -Income Available to Common Excl. Extra Items 58.9 40.62Income Available to Common Incl. Extra Items 58.9 40.62Basic Weighted Average Shares 4 3Basic EPS Excluding Extraordinary Items 8.65 8.42Basic EPS Including Extraordinary Items 8.65 8.42Dilution Adjustment 0 -Diluted Weighted Average Shares 4.3498 2.5639Diluted EPS Excluding Extraordinary Items 8.65 8.42Diluted EPS Including Extraordinary Items - -
Dividends per Share - Common Stock Primary Issue - -Gross Dividends - Common Stock - -Net Income after Stock Based Comp. Expense - -Basic EPS after Stock Based Comp. Expense - -Diluted EPS after Stock Based Comp. Expense - -
Depreciation, Supplemental - -Total Special Items - -Normalized Income Before Taxes - -Effect of Special Items on Income Taxes - -Income Taxes Ex. Impact of Special Items - -Normalized Income After Taxes - -
Income statement
-
8/10/2019 Valuation Workbook
16/48
Normalized Income Avail to Common - -Basic Normalized EPS - -Diluted Normalized EPS 8.65 8.42
-
8/10/2019 Valuation Workbook
17/48
52 weeks ending
2011-09-24
52 weeks ending
2010-09-25
436.63 362.550.39 0.34
437.02 362.9351.15 311.99
85.87 50.910 00 0
3.24 2.430 0
- -17.69 9.3120.93 11.7464.94 39.17
27.72 16.39- -- -
37.22 22.7819.41 16.89
- -- -
19.41 16.890 0.02
- -- -
19.41 16.9
- -19.41 16.919.41 16.9
27 260.4 0.350.4 0.35
- -26.8918 26.0865
0.4 0.35- -
- -- -- -- -- -
- -- -- -- -- -- -
-
8/10/2019 Valuation Workbook
18/48
- -- -
0.4 0.35
-
8/10/2019 Valuation Workbook
19/48
In Millions of USD (except for per share
items) As of 2013-09-28 As of 2012-09-29 As of 2011-09-24
Cash & Equivalents 23.7 21.95 13.81Short Term Investments 165.04 29.69 31.52Cash and Short Term Investments 188.74 51.64 45.33Accounts Receivable - Trade, Net 241.53 169.88 134.54Receivables - Other 0 0 0Total Receivables, Net 241.53 169.88 134.54Total Inventory 121.13 87.72 57.11Prepaid Expenses - - -Other Current Assets, Total 165.04 29.69 24.54Total Current Assets 386.36 279.55 205.46Property/Plant/Equipment, Total - Gross 277.77 258.07 57.98Accumulated Depreciation, Total 26.92 15.64 13.22Goodwill, Net 0 0 0
Intangibles, Net 4179 4224 3536Long Term Investments 106215 92122 55618Other Long Term Assets, Total 5146 5478 3556Total Assets 207000 176064 116371Accounts Payable 22367 21175 14632Accrued Expenses 4782 3283 2428Notes Payable/Short Term Debt 0 0 0Current Port. of LT Debt/Capital Leases - - -Other Current liabilities, Total 16509 14084 10910Total Current Liabilities 43658 38542 27970Long Term Debt 16960 - -Capital Lease Obligations - - -
Total Long Term Debt 16960 0 0Total Debt 16960 0 0Deferred Income Tax 16489 13847 8159Minority Interest - - -Other Liabilities, Total 6344 5465 3627Total Liabilities 83451 57854 39756Redeemable Preferred Stock, Total - - -Preferred Stock - Non Redeemable, Net - - -Common Stock, Total 19764 16422 13331Additional Paid-In Capital - - -
Retained Earnings (Accumulated Deficit) 104256 101289 62841Treasury Stock - Common - - -Other Equity, Total -191 731 130Total Equity 123549 118210 76615Total Liabilities & Shareholders' Equity 207000 176064 116371
Shares Outs - Common Stock Primary Issue - - -Total Common Shares Outstanding 6294.37 6574.46 6504.94
Balance sheet
-
8/10/2019 Valuation Workbook
20/48
-
8/10/2019 Valuation Workbook
21/48
As of 2010-09-25
In Millions of USD (except for per share
items)
52 weeks ending
2013-09-28
7.24 Net Income/Starting Line 3703735.3 Depreciation/Depletion 6757
42.54 Amortization -106.54 Deferred Taxes 1141
0 Non-Cash Items 2253106.54 Changes in Working Capital 6478
45.71 Cash from Operating Activities 53666- Capital Expenditures -9076
27.46 Other Investing Cash Flow Items, Total -24698159.49 Cash from Investing Activities -33774
48.02 Financing Cash Flow Items -38112.06 Total Cash Dividends Paid -10564
0 Issuance (Retirement) of Stock, Net -22330
342 Issuance (Retirement) of Debt, Net 1689625391 Cash from Financing Activities -163792263 Foreign Exchange Effects -
75183 Net Change in Cash 351312015 Cash Interest Paid, Supplemental -1593 Cash Taxes Paid, Supplemental 9128
0-
711420722
--
00
4300-
237027392
--
10668-
37169-
1714779175183
-6411.79
Cash flow statement
-
8/10/2019 Valuation Workbook
22/48
-
8/10/2019 Valuation Workbook
23/48
52 weeks ending
2012-09-29
52 weeks ending
2011-09-24
52 weeks ending
2010-09-25
41733 25922 140133277 1814 1027
- - -4405 2868 14401740 1168 903-299 5757 1212
50856 37529 18595-9402 -7452 -2121
-38825 -32967 -11733-48227 -40419 -13854
125 613 345-2488 0 -
665 831 912
- - --1698 1444 1257
- - -931 -1446 5998
- - -7682 3338 2697
-
8/10/2019 Valuation Workbook
24/48
-
8/10/2019 Valuation Workbook
25/48
20% annualy
25%9%
5%12
$47.00$ 10.052.13%
0.9431.00%21.00%27.56%
4.35
$24$13
$0
Enterprise Value $17,254.45
Month AVG P/E PRICE/ SALES PRICE/ BOOKNET PROFITMARGIN (%)
9/4/2014 54.6 1.8 3.0 3.39/5/2014 34.4 3.3 6.0 9.69/6/2014 34.0 3.5 6.6 10.3
9/7/2014 39.1 5.7 9.2 14.69/8/2014 21.2 3.2 4.5 14.99/9/2014 20.4 3.9 5.3 19.2
9/10/2014 18.7 4.0 5.4 21.59/11/2014 13.8 3.3 4.6 23.99/12/2014 15.1 4.0 5.3 26.79/13/2014 12.0 2.6 3.5 21.7
Growth decline rate
Conservatism inputsDesired return on investmentMargin of SafetyDiscount rate
Shares outstanding (Cr)
Year 10 FCF multiplier
Valuation inputsPriceEPSDividend YieldCurrent ratioPast 5 years EPS growth per yearNext 5 years EPS growth per yearSustainable Growth Rate
Cash and Short Term InvestmentsCash from Operating ActivitiesCapital Expenditures
There is a known bug with the dates in the two tables above. It should be read as M/Y/D.
-
8/10/2019 Valuation Workbook
26/48
BOOKVALUE/SHARE
DEBT/EQUITY
9/4/2014 0.9 NA9/5/2014 1.3 NA9/6/2014 1.7 NA
9/7/2014 2.4 NA9/8/2014 3.6 NA9/9/2014 5.0 NA
9/10/2014 7.5 NA9/11/2014 11.8 NA9/12/2014 18.0 NA9/13/2014 19.6 0.1
There is a known bug with the dates in the two tables above. It should
-
8/10/2019 Valuation Workbook
27/48
RETURN ON EQUITY(%)
RETURN ON
ASSETS
(%)
INTERESTCOVERAGE
5.9 3.7 NA21.3 13.6 NA22.8 13.8 NA
28.5 16.4 NA27.2 14.9 NA31.3 18.9 NA35.3 22.8 NA41.7 27.1 NA42.8 28.5 NA30.6 19.3 369.8
be read as M/Y/D.
-
8/10/2019 Valuation Workbook
28/48
Variable Value JudgementReturn on Equity 30.6 Good
Debt/Equity 0.14 Good
Conservative PEG ratio 0.40 Good
P/E ratio 4.68 Good
Net margin Stable/Increasing Good
Bookvalue per share Stable/Increasing Good
Next 5yr EPS growth rate 21.00% Relatively low
FCF yield 0.08% Low
Asset turnover change 16.62% GoodCurrent ratio 0.94 Bad
Altman Z Score -0.24 Bad
Accrual profit $8.65 Reasonable
Defensive profit $7.08 Positive & increasingEnterprising profit 0.06% Bad
Debt Repayment Period 0.38 Good
Value versus PriceAvg intrinsic value estimate $143,817.67 ReasonableCurrent price $47.00
Undervalued 305895.05%Max purchase price $88,928.00
#REF!
-
8/10/2019 Valuation Workbook
29/48
-
8/10/2019 Valuation Workbook
30/48
-
8/10/2019 Valuation Workbook
31/48
0.0
10.0
20.0
30.0
40.0
50.0
60.0
AverageP/E
Average P/E
0.0
1.0
2.0
3.0
4.0
5.0
6.0
7.0
8.0
9.0
10.0
Price/Book
Time >
Price/Book
0.1
0.2
Debt/Equity
-
8/10/2019 Valuation Workbook
32/48
0.0
0.0
0.0
0.0
0.1
0.1
0.1
0.1
Bookvaluepershare
Time >
-
8/10/2019 Valuation Workbook
33/48
0.0
1.0
2.0
3.0
4.0
5.0
6.0
Price/Sales
Time >
Price/Sales
0.0
5.0
10.0
15.0
20.0
25.0
30.0
Netmargin(%)
Time >
Net margin (%)
25.0
Book value per share
-
8/10/2019 Valuation Workbook
34/48
0.0
5.0
10.0
15.0
20.0
De
bt/Equity
Time >
-
8/10/2019 Valuation Workbook
35/48
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
40.0
45.0
50.0
ReturnonEquity
Time >
Return on Equity
0.0
5.0
10.0
15.0
20.0
25.0
30.0
35.0
ReturnonAssets
Time >
Return on Assets
-
8/10/2019 Valuation Workbook
36/48
-
8/10/2019 Valuation Workbook
37/48
-
8/10/2019 Valuation Workbook
38/48
-
8/10/2019 Valuation Workbook
39/48
$272InputsPrice 47
EPS 10.05
Median historical P/E 20.82Expected growth rate 21.00%
Margin of Safety 0.25
Conservative growth rate 15.75%
Growth decline rate 0.05Discount rate 0.09
CalculationsYear EPS*Growth rate
1 $11.632 $13.473 $15.484 $17.685 $20.07
Value in 5 years $417.81Present value $271.55
P/E valuation
-
8/10/2019 Valuation Workbook
40/48
-
8/10/2019 Valuation Workbook
41/48
-$3,796InputsTotal cash (mil $) $23.70
Free cash flow (mil $) $13.28
Shares outstanding (mil) 4.35Expected growth rate 21.00%
Margin of Safety 25.00%
Conservative growth rate 15.75%
Growth decline rate 5.00%Discount rate 9.00%Valuation last FCF 12
CalculationsYear FCF * Growth rate NPV FCF
1 $ 15.37 $ 15.372 $ 17.67 $ 16.213 $ 20.18 $ 16.994 $ 22.91 $ 17.695 $ 25.85 $ 18.316 $ 29.00 $ 18.857 $ 32.36 $ 19.298 $ 35.91 $ 19.659 $ 39.67 $ 19.91
10 $ 43.60 $ 20.08
Total NPV FCF $ 182.34
Year 10 FCF value $ 240.92Cash on Hand $ 23.70Total Debt $ 16,960.00
Company value: -$ 16,513.04
DCF valuation
-
8/10/2019 Valuation Workbook
42/48
-
8/10/2019 Valuation Workbook
43/48
#####InputsShareholders equity $123,549.00
Return on Equity (avg) 36.34%
Shares outstanding 4.35Dividend Yield 2.13%
Dividend payout ratio 9.95%
Margin of Safety 25.00%
Conservative growth rate 24.54%Discount rate 9.00%
Calculations (per share)Year Shareholders equity Dividend NPV dividends
1 $ 35,374.43 $ 1.25 $ 1.252 $ 44,056.40 $ 1.55 $ 1.423 $ 54,869.19 $ 1.93 $ 1.634 $ 68,335.77 $ 2.41 $ 1.865 $ 85,107.45 $ 3.00 $ 2.126 $ 105,995.43 $ 3.73 $ 2.437 $ 132,009.95 $ 4.65 $ 2.778 $ 164,409.23 $ 5.79 $ 3.179 $ 204,760.28 $ 7.21 $ 3.62
10 $ 255,014.72 $ 8.98 $ 4.13
Year 10 net income $ 92,672.35
Required value $ 1,029,692.78
NPV required value $ 434,953.36NPV dividends $ 24.39 '+
Intrinsic value: $ 434,977.75
ROE valuation
-
8/10/2019 Valuation Workbook
44/48
-
8/10/2019 Valuation Workbook
45/48
Earnings Power
Year 2013 2012 2011Accrual profit $8.65 $8.42 $0.40Defensive profit $7.08 $6.31 $4.62Enterprising profit 0.06% 0.05% 0.05%
Debt Repayment Period 0.38 0.00 0.00
http://www.valuespreadsheet.com/value-investing-blog/earnings-manipulation-detect-value-trap
Learn more about Earnings Power here:
$0.00
$1.00
$2.00
$3.00
$4.00
$5.00
$6.00
$7.00
$8.00
$9.00
$10.00
Quality of Profits
Accrual profit Defensive profit Enterprising profit
-
8/10/2019 Valuation Workbook
46/48
2010$0.35$2.57
0.05%
0.00
-hewitt-heiserman*Slightly different from the original Earnings Power Chart
0.00%
0.01%
0.02%
0.03%
0.04%
0.05%
0.06%
0.07%
$0.00 $2.00 $4.00 $6.00 $8.00
Enterprisingpro
fits
Defensive profits
Earnings Power chart*
-
8/10/2019 Valuation Workbook
47/48
Altman Z Score -0.24
InputsWorking capital -$43,271.64Total assets $207,000.00Retained earnings $39.37EBIT $195.16Sales $911.57Market value of equity $318.15Total liabilities $83,451.00
Learn more about the Altman-Z score here:http://www.investopedia.com/terms/a/altman.asp
-
8/10/2019 Valuation Workbook
48/48